Megan R. Carey is a Group Leader in the Neuroscience Program at the Champalimaud Center for the Unknown in Lisbon, Portugal. She received her PhD in 2005 from the University of California, San Francisco, where her thesis was awarded UCSF’s Krevans Distinguished Dissertation Award. After a Helen Hay Whitney Postdoctoral Fellowship at Harvard Medical School, Dr. Carey started her independent laboratory at the Champalimaud. Her lab combines quantitative behavioral analysis, genetics, and physiology to understand how the brain controls learned and coordinated movements.
Dr. Carey was an International Early Career Scientist of the Howard Hughes Medical Institute and her lab is funded by the European Research Council. She serves on the Board of Reviewing Editors for eLife and the Board of Directors of the Society for the Neural Control of Movement and the ALBA Network for Equity and Diversity in Brain Sciences. She has co-Chaired the Gordon Research Conference on the Cerebellum, COSYNE, and the FENS-Cajal summer course on the Behavior of Neural Systems. Dr. Carey has taken on broader leadership roles within Europe as the Chair of the FENS Kavli Network of Excellence (a network of early-mid career European neuroscience PIs), and as a high-level policy advisor to the European Commissioner for Research & Innovation.